Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia
- 1 June 1993
- journal article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 92 (2-3) , 197-201
- https://doi.org/10.1007/bf01244878
Abstract
Chronic haloperidol treatment in rats results in behavioural supersensitivity to dopamine agonists. This mechanism has been suggested as a possible animal model for tardive dyskinesia. In the present study the simultaneous administration of vitamin E to chronic haloperidol treatment in rats prevented the development of behavioural supersensitivity to apomorphine. This finding suggest that the concomitant administration of vitamin E to neuroleptics might prevent the development of tardive dyskinesia in humans.Keywords
This publication has 14 references indexed in Scilit:
- Tolerance and safety of vitamin E: A toxicological position reportFree Radical Biology & Medicine, 1992
- ??-Tocopherol Treatment for Tardive DyskinesiaJournal of Nervous & Mental Disease, 1992
- Alpha-tocopherol in the Treatment of Tardive DyskinesiaClinical Neuropharmacology, 1992
- Oxygen Radicals and Neuropsychiatric IllnessArchives of General Psychiatry, 1991
- Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesiaBiological Psychiatry, 1990
- Vitamin E in the Treatment of Tardive Dyskinesia: The Possible Involvement of Free Radical MechanismsSchizophrenia Bulletin, 1988
- Free radicals and tardive dyskinesiaTrends in Neurosciences, 1986
- Animal Models of Tardive DyskinesiasClinical Neuropharmacology, 1983
- The Role of Vitamin E in Biological MembranesPublished by Wiley ,1983
- Increased Brain Dopamine and Dopamine Receptors in SchizophreniaArchives of General Psychiatry, 1982